Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28973835 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL16167211 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL11147510 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL28973833 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL28973834 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL25171285 | 1.00 | TSHR (0.62) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL2001721 | 0.98 | TSHR (0.58) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL9694557 | 0.96 | TSHR (0.70) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL25178119 | 0.96 | TSHR (0.70) | TSHRALDH1A1ACE2ADH1BADH1C | |
| SCHEMBL16167241 | 0.96 | TSHR (0.70) | TSHRALDH1A1ACE2ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-114716599-B | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| CN-114716599-A | Olefin copolymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2020256852-A1 | AMPHIPHILIC REACTION PRODUCTS FROM LIGHTLY BRANCHED OLEFINS AND METHODS FOR PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-12-24 | — | — | WO | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-05-26 | — | — | US | disclosed |
| EP-2984055-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | Materia, Inc. (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2015126462-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
| WO-2014169080-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2014-10-16 | — | — | WO | disclosed |
| US-5331086-A | Deashing process for polyolefins using an alpha,beta-unsaturated ketone | PHILLIPS PETROLEUM COMPANY (US) | 1994-07-19 | — | — | US | disclosed |
| EP-0023018-B1 | METHOD OF REDUCING THE LEVEL OF CATALYST RESIDUES IN POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1986-01-15 | — | — | EP | disclosed |
| EP-0023018-A1 | Method of reducing the level of catalyst residues in polymers | PHILLIPS PETROLEUM COMPANY (US) | 1981-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, EPHX2, SMURF1 | TSHR 4332/4885ALDH1A1 1887/4885ACE2 536/4885 |
| US-20160145204-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, SMURF1, ABCB4 | TSHR 3892/4885ALDH1A1 3135/4885ACE2 406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.